125 related articles for article (PubMed ID: 805315)
1. [Proceedings: Immunology of Mycobacterium and its infection].
Kekkaku; 1975 Mar; 50(3):49-57. PubMed ID: 805315
[No Abstract] [Full Text] [Related]
2. [Immunology of tuberculosis].
Tokunaga T
Kekkaku; 1982 Sep; 57(9):455-65. PubMed ID: 6816977
[No Abstract] [Full Text] [Related]
3. Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis, M. vaccae, and M. bovis (BCG).
Sinha S; Sreevatsa ; Gupta SK; Sengupta U
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):42-53. PubMed ID: 2435824
[TBL] [Abstract][Full Text] [Related]
4. [Transfer of the cytotoxic activity of lymphocytes immune to M. tuberculosis].
Averbakh MM; Kliuev VA; Litvinov VI
Biull Eksp Biol Med; 1973 Jun; 75(6):76-9. PubMed ID: 4204961
[No Abstract] [Full Text] [Related]
5. Delayed type hypersensitivity and antituberculous immunity.
Averbakh MM; Gergert VY; Kluyev VA; Kolodiazhnaya NS; Litvinsov VI; Moroz AM
Z Immunitatsforsch Exp Klin Immunol; 1974 Aug; 147(3):204-16. PubMed ID: 4283014
[No Abstract] [Full Text] [Related]
6. Safety of ESAT-6.
Aggerbeck H; Madsen SM
Tuberculosis (Edinb); 2006 Sep; 86(5):363-73. PubMed ID: 16352469
[TBL] [Abstract][Full Text] [Related]
7. [Immunology of tuberculosis].
Estrada-Parra S; García Procel E
Salud Publica Mex; 1982; 24(3):269-78. PubMed ID: 6815811
[No Abstract] [Full Text] [Related]
8. Production and purification of eta (ETA) precipitinogen, species-specific to mycobacterium tuberculosis and its intradermal reactivity.
Hirai T; Yamanouchi T
Dev Biol Stand; 1986; 58 ( Pt B)():565-8. PubMed ID: 3111903
[TBL] [Abstract][Full Text] [Related]
9. [A review on mechanism of anti-tumor action of BCG (author's transl)].
Tokunaga T
Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
[No Abstract] [Full Text] [Related]
10. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.
Dannenberg AM; Collins FM
Tuberculosis (Edinb); 2001; 81(3):229-42. PubMed ID: 11466035
[TBL] [Abstract][Full Text] [Related]
11. An experimental model for immunotherapy of cancer.
Zbar B; Ribi E; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
[No Abstract] [Full Text] [Related]
12. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
13. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model.
Dannenberg AM
Tuberculosis (Edinb); 2001; 81(1-2):87-96. PubMed ID: 11463228
[No Abstract] [Full Text] [Related]
14. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.
Basaraba RJ; Izzo AA; Brandt L; Orme IM
Vaccine; 2006 Jan; 24(3):280-6. PubMed ID: 16153758
[TBL] [Abstract][Full Text] [Related]
15. Perspectives for BCG standardization.
Lévy FM; Mande R; Conge G; Fillastre C; Orssaud E
Bibl Tuberc; 1968; 24():63-190. PubMed ID: 4984263
[No Abstract] [Full Text] [Related]
16. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
17. [Chemistry and biological activities of the components of Mycobacterium tuberculosis].
Azuma I; Yamamura Y
Kekkaku; 1975 Dec; 50(11):429-40. PubMed ID: 815693
[No Abstract] [Full Text] [Related]
18. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG
Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy of tuberculosis (literature review)].
Averbakh MM; Litvinov VI
Probl Tuberk; 1976 Apr; (4):65-70. PubMed ID: 824645
[No Abstract] [Full Text] [Related]
20. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.
Olsen AW; Williams A; Okkels LM; Hatch G; Andersen P
Infect Immun; 2004 Oct; 72(10):6148-50. PubMed ID: 15385521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
